Annual CFO
-$100.75 M
-$28.28 M-39.03%
December 31, 2023
Summary
- As of February 8, 2025, ATHA annual cash flow from operations is -$100.75 million, with the most recent change of -$28.28 million (-39.03%) on December 31, 2023.
- During the last 3 years, ATHA annual CFO has fallen by -$76.64 million (-317.84%).
- ATHA annual CFO is now -2613.52% below its all-time high of -$3.71 million, reached on December 31, 2019.
Performance
ATHA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$23.02 M
-$693.00 K-3.10%
September 30, 2024
Summary
- As of February 8, 2025, ATHA quarterly cash flow from operations is -$23.02 million, with the most recent change of -$693.00 thousand (-3.10%) on September 30, 2024.
- Over the past year, ATHA quarterly CFO has increased by +$3.27 million (+12.44%).
- ATHA quarterly CFO is now -1859.40% below its all-time high of -$1.18 million, reached on March 31, 2020.
Performance
ATHA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$97.45 M
+$961.00 K+0.98%
September 30, 2024
Summary
- As of February 8, 2025, ATHA TTM cash flow from operations is -$97.45 million, with the most recent change of +$961.00 thousand (+0.98%) on September 30, 2024.
- Over the past year, ATHA TTM CFO has increased by +$3.30 million (+3.28%).
- ATHA TTM CFO is now -8193.62% below its all-time high of -$1.18 million, reached on March 31, 2020.
Performance
ATHA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ATHA Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -39.0% | +12.4% | +3.3% |
3 y3 years | -317.8% | +12.4% | +3.3% |
5 y5 years | -2147.4% | +12.4% | +3.3% |
ATHA Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -133.8% | at low | -47.0% | +12.4% | -126.1% | +3.3% |
5 y | 5-year | -2613.5% | at low | -1859.4% | +12.4% | -8193.6% | +3.3% |
alltime | all time | -2613.5% | at low | -1859.4% | +12.4% | -8193.6% | +3.3% |
Athira Pharma Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$23.02 M(+3.1%) | -$97.45 M(-1.0%) |
Jun 2024 | - | -$22.33 M(-13.5%) | -$98.41 M(-1.9%) |
Mar 2024 | - | -$25.80 M(-1.9%) | -$100.36 M(-0.4%) |
Dec 2023 | -$100.75 M(+39.0%) | -$26.29 M(+9.6%) | -$100.75 M(+11.8%) |
Sep 2023 | - | -$23.98 M(-1.2%) | -$90.13 M(+2.7%) |
Jun 2023 | - | -$24.28 M(-7.3%) | -$87.78 M(+6.9%) |
Mar 2023 | - | -$26.19 M(+67.2%) | -$82.09 M(+13.3%) |
Dec 2022 | -$72.47 M | -$15.67 M(-27.6%) | -$72.47 M(-3.3%) |
Sep 2022 | - | -$21.64 M(+16.4%) | -$74.98 M(+17.8%) |
Jun 2022 | - | -$18.59 M(+12.2%) | -$63.64 M(+21.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$16.57 M(-8.8%) | -$52.37 M(+21.5%) |
Dec 2021 | -$43.10 M(+78.7%) | -$18.18 M(+76.5%) | -$43.10 M(+21.1%) |
Sep 2021 | - | -$10.30 M(+40.8%) | -$35.59 M(+2.6%) |
Jun 2021 | - | -$7.32 M(+0.2%) | -$34.70 M(+14.7%) |
Mar 2021 | - | -$7.30 M(-31.5%) | -$30.24 M(+25.4%) |
Dec 2020 | -$24.11 M(+549.4%) | -$10.66 M(+13.3%) | -$24.11 M(+79.3%) |
Sep 2020 | - | -$9.41 M(+228.8%) | -$13.45 M(+233.1%) |
Jun 2020 | - | -$2.86 M(+143.6%) | -$4.04 M(+243.6%) |
Mar 2020 | - | -$1.18 M | -$1.18 M |
Dec 2019 | -$3.71 M(-17.2%) | - | - |
Dec 2018 | -$4.48 M | - | - |
FAQ
- What is Athira Pharma annual cash flow from operations?
- What is the all time high annual CFO for Athira Pharma?
- What is Athira Pharma annual CFO year-on-year change?
- What is Athira Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Athira Pharma?
- What is Athira Pharma quarterly CFO year-on-year change?
- What is Athira Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Athira Pharma?
- What is Athira Pharma TTM CFO year-on-year change?
What is Athira Pharma annual cash flow from operations?
The current annual CFO of ATHA is -$100.75 M
What is the all time high annual CFO for Athira Pharma?
Athira Pharma all-time high annual cash flow from operations is -$3.71 M
What is Athira Pharma annual CFO year-on-year change?
Over the past year, ATHA annual cash flow from operations has changed by -$28.28 M (-39.03%)
What is Athira Pharma quarterly cash flow from operations?
The current quarterly CFO of ATHA is -$23.02 M
What is the all time high quarterly CFO for Athira Pharma?
Athira Pharma all-time high quarterly cash flow from operations is -$1.18 M
What is Athira Pharma quarterly CFO year-on-year change?
Over the past year, ATHA quarterly cash flow from operations has changed by +$3.27 M (+12.44%)
What is Athira Pharma TTM cash flow from operations?
The current TTM CFO of ATHA is -$97.45 M
What is the all time high TTM CFO for Athira Pharma?
Athira Pharma all-time high TTM cash flow from operations is -$1.18 M
What is Athira Pharma TTM CFO year-on-year change?
Over the past year, ATHA TTM cash flow from operations has changed by +$3.30 M (+3.28%)